Organon & Co. (OGN)
13.76
0.00 (0.00%)
USD |
NYSE |
Oct 16, 16:00
13.76
0.00 (0.00%)
After-Hours: 20:00
Organon Free Cash Flow : 558.00M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 558.00M |
| March 31, 2026 | 708.00M |
| December 31, 2025 | 508.00M |
| September 30, 2025 | 598.00M |
| June 30, 2025 | 537.00M |
| March 31, 2025 | 641.00M |
| December 31, 2024 | 693.00M |
| September 30, 2024 | 721.00M |
| June 30, 2024 | 839.00M |
| March 31, 2024 | 510.00M |
| December 31, 2023 | 540.00M |
| September 30, 2023 | 548.00M |
| Date | Value |
|---|---|
| June 30, 2023 | 444.00M |
| March 31, 2023 | 555.00M |
| December 31, 2022 | 555.00M |
| September 30, 2022 | 464.00M |
| June 30, 2022 | 179.00M |
| March 31, 2022 | 1.525B |
| December 31, 2021 | 2.162B |
| September 30, 2021 | 2.193B |
| June 30, 2021 | 2.66B |
| March 31, 2021 | 2.003B |
| December 31, 2020 | 1.932B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 16.06B |
| Viatris, Inc. | 1.806B |
| Pfizer Inc. | 10.99B |
| Pacira Biosciences, Inc. | 179.52M |
| Bristol Myers Squibb Co. | 11.44B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 107.00M |
| Cash from Investing (Quarterly) | -76.00M |
| Cash from Financing (Quarterly) | -12.00M |
| Free Cash Flow Per Share (Quarterly) | 0.1146 |
| Free Cash Flow to Equity (Quarterly) | 47.00M |
| Free Cash Flow to Firm (Quarterly) | 96.51M |
| Free Cash Flow Yield | 15.39% |